Affinity Asset Advisors, LLC Centessa Pharmaceuticals PLC Transaction History

Affinity Asset Advisors, LLC

  • $896 Million
  • Q1 2025

A detailed history of Affinity Asset Advisors, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 1,546,662 shares of CNTA stock, worth $26.6 Million. This represents 2.48% of its overall portfolio holdings.

Number of Shares
1,546,662
Previous 1,095,924 41.13%
Holding current value
$26.6 Million
Previous $18.4 Million 21.16%
% of portfolio
2.48%
Previous 3.28%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$14.38 - $19.03 $6.48 Million - $8.58 Million
450,738 Added 41.13%
1,546,662 $22.2 Million
Q4 2024

Feb 13, 2025
BUY
$15.04 - $18.67 $1.96 Million - $2.43 Million
130,312 Added 13.5%
1,095,924 $18.4 Million
Q3 2024

Nov 13, 2024
SELL
$8.58 - $16.99 $1.46 Million - $2.89 Million
-170,090 Reduced 14.98%
965,612 $15.4 Million
Q2 2024

Aug 14, 2024
BUY
$8.04 - $11.87 $2.45 Million - $3.62 Million
305,156 Added 36.74%
1,135,702 $10.3 Million
Q1 2024

May 14, 2024
BUY
$6.73 - $12.2 $234,318 - $424,767
34,817 Added 4.38%
830,546 $9.39 Million
Q4 2023

Feb 13, 2024
SELL
$5.52 - $8.03 $1.23 Million - $1.79 Million
-222,362 Reduced 21.84%
795,729 $6.33 Million
Q3 2023

Nov 14, 2023
BUY
$6.01 - $8.24 $705,381 - $967,112
117,368 Added 13.03%
1,018,091 $6.59 Million
Q2 2023

Aug 14, 2023
BUY
$3.68 - $6.9 $797,073 - $1.49 Million
216,596 Added 31.66%
900,723 $5.58 Million
Q1 2023

May 15, 2023
BUY
$3.03 - $4.0 $678,110 - $895,196
223,799 Added 48.62%
684,127 $2.63 Million
Q4 2022

Feb 13, 2023
BUY
$3.05 - $4.19 $664,323 - $912,628
217,811 Added 89.81%
460,328 $1.43 Million
Q3 2022

Nov 14, 2022
BUY
$3.8 - $5.91 $921,564 - $1.43 Million
242,517 New
242,517 $975,000
Q2 2022

Aug 12, 2022
SELL
$3.18 - $9.85 $207,596 - $643,027
-65,282 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$7.45 - $11.59 $2.64 Million - $4.1 Million
-353,862 Reduced 84.42%
65,282 $586,000
Q4 2021

Feb 11, 2022
BUY
$10.99 - $17.54 $2.37 Million - $3.79 Million
215,961 Added 106.29%
419,144 $4.72 Million
Q3 2021

Nov 12, 2021
BUY
$16.7 - $23.11 $2.27 Million - $3.15 Million
136,226 Added 203.45%
203,183 $3.39 Million
Q2 2021

Aug 13, 2021
BUY
$21.71 - $25.66 $1.45 Million - $1.72 Million
66,957 New
66,957 $1.49 Million

Others Institutions Holding CNTA

# of Institutions
135
Shares Held
123M
Call Options Held
163K
Put Options Held
816K
View Full List

About Centessa Pharmaceuticals plc

CNTA Quotes by TradingView
  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.62B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email